PHOTOBIOMODULATION ON MUSCLE STRENGTH AND FATIGUE IN MULTIPLE SCLEROSIS: SYSTEMATIC REVIEW
DOI:
https://doi.org/10.21776/ub.mnj.2024.010.02.11Keywords:
systematic review, low-intensity laser therapy, multiple sclerosisAbstract
Background: Photobiomodulation plays an important role in modulating the inflammatory process, accelerating tissue repair, which can be beneficial in cases such as multiple sclerosis.
Objective: To carry out a literature review about effectiveness of photobiomodulation on muscle strength and fatigue in multiple sclerosis.
Methods: The databases included were PubMed, Embase, Cochrane, Web of Science, Scopus and LILACS (Latin American and Caribbean Health Sciences Literature). Also the gray literature: Google Scholar, LIVIVO (ZB MED Search Portal for Life Sciences), Open Grey and Library of Thesis and Dissertations CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). The risk of bias was assessed using the Cochrane tool, Rob 2, and the data was extracted and assessed by blinded reviewers.
Results: Initially 7302 records were found, 7102 in the main databases and 200 in the gray literature. After removing duplicates, 4217 studies were left for Phase 1 and 10 for Phase 2. Finally, 3 randomized clinical trials were included in this review.
Conclusion: The studies included risk of bias in this review was predominantly low. PBM proved to be effective in improving muscle strength, but not fatigue. However, the number of human clinical trials is still too few for a more conclusive analysis.
Downloads
References
Malekzadeh A, Van De Geer-Peeters W, De Groot V, Elisabeth Teunissen C, Beckerman H, Study Group TA. Fatigue in patients with multiple sclerosis: Is it related to pro- and anti-inflammatory cytokines? Dis Markers; 2015. Jan 19;2015:758314.
DOI: 10.1155/2015/758314
Chalah MA, Ayache SS. Is there a link between inflammation and fatigue in multiple sclerosis? J Inflamm Res; 2018. Jun 7;11:253–64.
DOI: 10.2147/JIR.S167199
Hossein-khannazer N, Arki MK, Keramatinia A, Rezaei-Tavirani M. The role of low-level laser therapy in the treatment of multiple sclerosis: A review study. J Lasers Med Sci; 2021. 12(1):e88.
DOI: 10.34172/jlms.2021.88
Ghasemi M, Fatemi A. Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases. Neurosci Biobehav Rev; 2014. 45:168–82. DOI: 10.1016/j.neubiorev.2014.06.002
Mercan F, Kara B, Tiftikcioglu BI, Mercan E, Sertpoyraz FM. Effects of motor-motor and motor-cognitive tasks on balance in patients with multiple sclerosis. Mult Scler Relat Disord; 2016. May 1;7:85–91. DOI: 10.1016/j.msard.2016.03.015
Chitnis T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int Rev Neurobiol; 2007. 79:43–72. DOI: 10.1016/S0074-7742(07)79003-7
Wang K, Song F, Fernandez-Escobar A, Luo G, Wang JH, Sun Y. The properties of cytokines in multiple sclerosis: Pros and cons. American Journal of the Medical Sciences; 2018. Dec 1;356(6):552–60.
DOI: 10.1016/j.amjms.2018.08.018
Kubsik A, Klimkiewicz R, Janczewska K, Klimkiewicz P, Jankowska A, Woldaska-Okoska M. Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis. NeuroRehabilitation; 2016. Mar 19;38(2):183–90. DOI: 10.3233/NRE-161309
Freitas LF de, Hamblin MR. Proposed mechanisms of photobiomodulation or low-Level light therapy. IEEE Journal of Selected Topics in Quantum Electronics; 2016. May 1;22(3):348–64.
DOI: 10.1109/JSTQE.2016.2561201
Kjølhede T, Dalgas U, Gade AB, Bjerre M, Stenager E, Petersen T, et al. Acute and chronic cytokine responses to resistance exercise and training in people with multiple sclerosis. Scand J Med Sci Sports; 2016. Jul 1;26(7):824–34. DOI: 10.1111/sms.12504
Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM and R; 2010. 2(12 SUPPL):S292–305. DOI: 10.1016/j.pmrj.2010.10.013
Tomé RFF, Silva DFB, Santos CAO dos, Neves G de V, Rolim AKA, Gomes DQ de C. ILIB (intravascular laser irradiation of blood) as an adjuvant therapy in the treatment of patients with chronic systemic diseases-an integrative literature review. Lasers Med Sci [Internet]; 2020;35(9):1899–907. DOI: 10.1007/s10103-020-03100-4
Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ; 2011. 343(2):d5928–d5928. DOI: 10.1136/bmj.d5928
Rouhani M, Tolentino M, Queoff E, Cho C, Lyons JA, Ng A V. Chronic effect of photobiomodulation therapy on muscle function in persons with multiple sclerosis. Med Sci Sports Exerc; 2021. 53(8S):122–3.
DOI: 10.1249/01.mss.0000760564.99937.e3
Rouhani M, Tolentino M, Queoff E, Cho C, Lyons JA, Ng A V. Acute effects of photobiomodulation therapy on muscle force recovery in persons with multiple sclerosis. Med Sci Sports Exerc; 2020. Jul;52(7S):78–78. DOI: 10.1249/01.mss.0000670892.38427.23
Silva T, Alencar RC, de Souza Silva BC, Viana ECOM, Fragoso YD, Gomes AO, et al. Effect of photobiomodulation on fatigue in individuals with relapsing–remitting multiple sclerosis: A pilot study. Lasers Med Sci; 2022. Oct 1;37(8):3107–13.
DOI: 10.1007/s10103-022-03567-3
Ayache SS, Chalah MA. Fatigue in multiple sclerosis – Insights into evaluation and management. Neurophysiologie Clinique; 2017. Apr 1;47(2):139–71. DOI: 10.1016/j.neucli.2017.02.004
Morrison JD, Stuifbergen AK. Predictors of fatigue impact in persons with long-standing multiple sclerosis. Journal of Neuroscience Nursing; 2016. Jun 1;48(3):143–50.
DOI: 10.1097/JNN.0000000000000208
Vafaei-Nezhad S, Niknazar S, Payvandi AA, Tehrani AS, Roozbahany NA, Ahrabi B, et al. Therapeutic effects of photobiomodulation therapy on multiple sclerosis by regulating the inflammatory process and controlling immune cell activity: A novel promising treatment target. J Lasers Med Sci; 2022. 13:e32.
DOI: 10.34172/jlms.2022.32
Von Leden RE, Cooney SJ, Ferrara TM, Zhao Y, Dalgard CL, Anders JJ, et al. 808 nm wavelength light induces a dose-dependent alteration in microglial polarization and resultant microglial induced neurite growth. Lasers Surg Med; 2013. Apr;45(4):253–63. DOI: 10.1002/lsm.22133
Bertin JSF, Marques MJ, Macedo AB, de Carvalho SC, Neto HS. Effect of photobiomodulation on denervation-induced skeletal muscle atrophy and autophagy: A study in mice. J Manipulative Physiol Ther; 2022. Feb 1;45(2):97–103.
DOI: 10.1016/j.jmpt.2022.03.011
Ferraresi C, Huang YY, Hamblin MR. Photobiomodulation in human muscle tissue: An advantage in sports performance? J Biophotonics; 2016. Dec 1;9(11–12):1273–99.
DOI: 10.1002/jbio.201600176
Miranda EF, Tomazoni SS, de Paiva PRV, Pinto HD, Smith D, Santos LA, et al. When is the best moment to apply photobiomodulation therapy (PBMT) when associated to a treadmill endurance-training program? A randomized, triple-blinded, placebo-controlled clinical trial. Lasers Med Sci; 2018. May 1;33(4):719–27. DOI: 10.1007/s10103-017-2396-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 MNJ (Malang Neurology Journal)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
